InvestorsHub Logo
Followers 5
Posts 2466
Boards Moderated 0
Alias Born 08/16/2016

Re: None

Saturday, 03/19/2022 2:44:11 AM

Saturday, March 19, 2022 2:44:11 AM

Post# of 3203
ACAD does not have enough time left on the Nuplazid patent to do another P3 trial for ADP, so that's why we and ACAD are screwed, because the FDA will reject this a 2nd time around :(
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News